|
Washington DC, USA, 26th
October 2004 (CNA) -
The United States
Conference of Catholic Bishops (USCCB) launched a
nationwide two-week ad campaign on stem-cell research
today.
The ads, aimed at
explaining the distinction between embryonic stem-cell
research and adult stem-cell research, will appear in
the New York Times, USA Today, the Washington Times, the
National Catholic Reporter and diocesan publications.
The campaign message is
that science does not have to kill in order to
cure.
Cathy Cleaver Ruse, Esq.,
director of Planning and Information for the USCCB's
Secretariat for Pro-Life Activities, explains that
embryonic stem-cell research requires the destruction of
human life at the embryonic stage.
"Adult stem-cell research
is already helping people with many diseases, including
heart disease, spinal cord injury, even Parkinson's
disease," she said, unlike embryonic stem-cell
research that “comes with a hefty price tag: the
deliberate destruction of human life.”
The USCCB had also put out
an an informational flyer, "Stem Cell Research and Human
Cloning: Questions and Answers."
To view the ad, go to:
http://www.usccb.org/prolife/stemcellads.htm. To view the flyer, go to:
http://www.usccb.org/prolife/stemcellQ&A.pdf.
|
